ESMO National Representative in United Kingdom
|Term||2012 – 2014|
Academic Unit of Clinical Oncology, Weston Park Hospital
Sheffield Cancer Research Centre
Prof. Coleman graduated from Kings College Hospital Medical School, University of London in 1978. Following clinical training in oncology in London and Edinburgh and completion of a research doctorate (MD) in the field of bone metastases, he became senior lecturer and honorary consultant in the newly formed Academic Unit of Clinical Oncology at Weston Park Hospital in 1991.
Following subsequent promotions to Reader in 1996 and Professor in 1999, he now leads a large clinical research team and is the director of the Gestational Trophoblastic Diseases Treatment Centre in Sheffield.
Since 2011, he has been an associate director of the National Cancer Research Network (NCRN). He is the Lead for the new CR-UK / YCR Sheffield Cancer Centre and was Chairman of the National Cancer Research Institute Breast Cancer Study Group in the UK (2004-09) and Past-President of the Cancer and Bone Society (2005-08).
Over the years, Robert Coleman has developed a highly successful cancer clinical trials facility, which has both led and participated in a broad range of clinical trials. These have ranged from early phase drug development studies to large phase III randomised trials. As research lead for clinical cancer research, he is responsible for running the Cancer Clinical Trials Centre, a purpose built clinical research facility that provides the research infrastructure for the North Trent Cancer Research Network, the Experimental Cancer Medicine Centre, and the breast cancer component of the bone oncology research laboratories within the medical school.
Prof. Coleman’s research interests include cancer-induced bone disease and developments in the management of breast cancer. He has authored or co-authored more than 300 publications of original research and is on the editorial board of several oncology journals including European Journal of Cancer, The Breast, Cancer Treatment Reviews and Journal of Bone Oncology.